Northland Capital partners view on Evgen Pharma PLC: The commencement of Evgen’s first Phase II clinical trial is a major milestone for the company. There have been no significant clinical
Dr Stephen Franklin, Evgen Pharma’s CEO LON:EVG, commented: “SAH is a rare and devastating condition, with a high unmet clinical need. Mechanistically, SFX-01 targets the principal drivers of the delayed
Evgen Pharma’s Dr Stephen Franklin discusses obtaining the required approval to start Phase II clinical trial on SFX-01 in this exclusive interview with DirectorsTalk
Evgen Pharma plc, the clinical stage drug development company focused on the treatment of cancer and neurological conditions, yesterday announced that it had received the required approvals for the commencement
Evgen Pharma Plc (LON:EVG) CEO Dr Stephen Franklin talks to DirectorsTalk about the SFX-01 trial approval for a type of stroke called a Subarachnoid Haemorrhage. Stephen explains what this is,
Northland Capital partners view: The commencement of Evgen’s first Phase II clinical trial will represent a major clinical milestone for the company. Moreover, SFX-01 has the possibility of qualifying for
Evgen Pharma plc (AIM: EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, has told DirectorsTalk that it has received the required approvals
Politics will exert considerable influence on markets in 2016 with November’s US presidential election, the UK in/out referendum expected over the summer and the escalating tensions in the Middle East.
Beaufort Securities view on Evgen Pharma (LON:EVG): This is an important and necessary appointment. Evgen is on course to commence two phase II clinical trials this year. This is the
Northland Capital partners view on Evgen Pharma PLC: Evgen is on track to commence two phase 2 clinical trials this year. The group is building a strong clinical team in
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
